Status:
COMPLETED
A Trial Evaluating Autologous Endometrial Co-Culture Versus Conventional Medium in the Treatment of Infertility
Lead Sponsor:
Clinique Ovo
Collaborating Sponsors:
Genevrier Laboratories
Conditions:
Infertility
Eligibility:
FEMALE
18-38 years
Phase:
NA
Brief Summary
One of the main factors in the success of in-vitro fertilization is the quality of the environment of the embryo. In contrast to maternal age, the environment in which the embryo develops is a modifia...
Eligibility Criteria
Inclusion
- Undergoing In Vitro Fertilization (IVF) or IVF/Intra Cytoplasmic Sperm Injection (ICSI) at OVO clinic
- Having a prescription of a long, short or an antagonist IVF protocols using both urinary and synthetic gonadotropins
- Having a single embryo transfer
- Regular menstrual cycles
- Basal follicle stimulating hormone levels less than 10 IU/l within 6 months prior to entering the study
- anti-mullerian hormone more than 1 ng/ml measured within a year
- Normal sonohysterogram or hysteroscopy done within the last 2 years
- Previously undergone a maximum of 3 IVF cycles
- Documented negative serology tests within 1 year prior recruitment for: Hepatitis B, Syphilis, HIV based on Health Canada recommendations for treatment in an IVF laboratory.
Exclusion
- Amenorrhea
- Anovulatory cycles
- Polycystic Ovarian syndrome
- Chronic endometritis
- Severe endometriosis
- Hydrosalpinx
- Uterine synechia or Asherman's syndrome
- Submucosal uterine fibroids or intra-cavitary polyps greater than 1cm
- Uterine anomalies
- Use of anticoagulants
- Secretory Azoospermia
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT01886118
Start Date
March 1 2013
End Date
October 1 2015
Last Update
December 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Ovo
Montreal, Quebec, Canada, H4P 2S4